etoposide has been researched along with bisbenzimidazole in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baguley, BC; Finlay, GJ | 1 |
| Suciu, D | 1 |
| Banáth, JP; Fjell, CD; Olive, PL | 1 |
| Kinzler, KW; Lengauer, C; Vogelstein, B; Waldman, T | 1 |
| Bernardi, R; Bürkle, A; Donzelli, M; Negri, C; Rossi, L; Scovassi, AI | 1 |
| Hartley, JA; Hochhauser, D; Tolner, B | 1 |
| Kayser, L; Landex, NL | 1 |
| Mimata, H; Nomura, T; Nomura, Y; Yamasaki, M | 1 |
8 other study(ies) available for etoposide and bisbenzimidazole
| Article | Year |
|---|---|
Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II.
Topics: Acridines; Amsacrine; Animals; Antineoplastic Agents; Benzimidazoles; Bisbenzimidazole; Colonic Neoplasms; Doxorubicin; Drug Synergism; Etoposide; Fluorescent Dyes; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1990 |
Reproductive death of Chinese hamster V79 cells after exposure to chemical inhibitors of DNA synthesis.
Topics: 4-Nitroquinoline-1-oxide; Amsacrine; Animals; Benzamides; Bisbenzimidazole; Cell Division; Cell Line; Cisplatin; Cricetinae; Cricetulus; Cycloheximide; DNA Replication; Etoposide; Gene Expression Regulation; In Vitro Techniques; Kinetics; Methylnitronitrosoguanidine; Puromycin; Teniposide; Transcription, Genetic; Uracil | 1991 |
DNA strand breakage and DNA structure influence staining with propidium iodide using the alkaline comet assay.
Topics: Alkalies; Animals; Bisbenzimidazole; Cell Line; Cricetinae; Cricetulus; DNA Damage; DNA, Single-Stranded; Electrophoresis, Agar Gel; Etoposide; Female; Fibroblasts; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Indoles; Lung; Male; Methylnitronitrosoguanidine; Microscopy, Fluorescence; Nucleic Acid Conformation; Nucleic Acid Denaturation; Propidium; Staining and Labeling; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1994 |
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21.
Topics: Antineoplastic Agents; Apoptosis; Bisbenzimidazole; Camptothecin; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Damage; Doxorubicin; Enzyme Inhibitors; Etoposide; Fluorescent Dyes; Gamma Rays; Humans; Mitosis; S Phase; Tumor Cells, Cultured | 1996 |
Multiparametric staining to identify apoptotic human cells.
Topics: Adenosine Diphosphate Ribose; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; Biotin; Bisbenzimidazole; Chromatin; DNA Fragmentation; Etoposide; Fluorescent Antibody Technique; Fluorescent Dyes; HeLa Cells; HL-60 Cells; Humans; Polymers; Staining and Labeling; Uracil Nucleotides | 1997 |
Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
Topics: 3T3 Cells; Animals; Antigens, Neoplasm; Benzimidazoles; Bisbenzimidazole; Cell Line; Distamycins; DNA Footprinting; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Gene Expression Regulation; Humans; Isoenzymes; Mice; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic | 2001 |
Optimization of an Acridine Orange-bisbenzimide procedure for the detection of apoptosis-associated fluorescence colour changes in etoposide-treated cell cultures.
Topics: Acridine Orange; Apoptosis; Bisbenzimidazole; Cell Line; Etoposide; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Nucleic Acid Synthesis Inhibitors; Staining and Labeling | 2004 |
Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.
Topics: Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Bisbenzimidazole; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Humans; Immunoblotting; Inhibitor of Apoptosis Proteins; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Neuronal Apoptosis-Inhibitory Protein; Paclitaxel; Phenotype; Prostatic Neoplasms; Survivin; Taxoids; Tetrazolium Salts; Time Factors; Ubiquitin-Protein Ligases; X-Linked Inhibitor of Apoptosis Protein | 2005 |